Relationship of 1 year hypokalemia incidence to clinical outcomes in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

被引：0
|
作者：
Alderman, Michael
Calhoun, David
Cushman, William
Davis, Barry
Eckfeldt, John
Einhorn, Paula
Ford, Charles
Franklin, Stanley
Furberg, Curt
Ong, Stephen
Oparil, Suzanne
Papademetriou, Vasilios
Piller, Linda
Probstfield, Jeffrey
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Univ Alabama, Birmingham, AL USA
[3] Memphis VAMC, Memphis, TN USA
[4] Univ Texas, Sch Publ Hlth, Houston, TX USA
[5] Univ Minnesota Hosp & Clin, Minneapolis, MN 55455 USA
[6] NHLBI, DHVD, Bethesda, MD 20892 USA
[7] Univ Calif Irvine, Los Angeles, CA USA
[8] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[9] Ong Med Ctr, Oxon Hill, MD USA
[10] VAMC Washington, Washington, DC USA
[11] Univ Washington, Seattle, WA 98195 USA
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：576 / 576
页数：1
相关论文
共 50 条
  • [31] Disseminating clinical trial results to promote public health: Case study from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (allhat)
    Katz, L.
    Bartholomew, L.
    Dawson, G.
    Pressel, S. L.
    Davis, B. R.
    Cushman, W.
    Whelton, P.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 : 193 - 193
  • [32] Heart failure with preserved and impaired left ventricular systolic function in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Davis, Barry R.
    Simpson, Lara M.
    Black, Henry R.
    Cushman, Wililam C.
    Einhorn, Paula T.
    Farber, Michael A.
    Ford, Charles E.
    Levy, Daniel
    Massie, Barry M.
    Nawaz, Shah
    Nawaz, Shah
    CIRCULATION, 2006, 114 (18) : 571 - 571
  • [33] Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
    Haywood, L. Julian
    Ford, Charles E.
    Crow, Richard S.
    Davis, Barry R.
    Massie, Barry M.
    Einhorn, Paula T.
    Williard, Angela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (22) : 2023 - 2031
  • [34] Follow-up specialists in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) - Contribution to study closeout
    Pressel, S
    Davis, B
    Blanton, J
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 116S - 117S
  • [35] Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])
    Alderman, Michael H.
    Davis, Barry R.
    Piller, Linda B.
    Ford, Charles E.
    Baraniuk, M. Sarah
    Pressel, Sara L.
    Assadi, Mahshid A.
    Einhorn, Paula T.
    Haywood, L. Julian
    Ilamathi, Ekambaram
    Oparil, Suzanne
    Retta, Tamrat M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (01): : 105 - 115
  • [36] Long-Term Renal and Cardiovascular Outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants by Baseline Estimated GFR
    Rahman, Mahboob
    Ford, Charles E.
    Cutler, Jeffrey A.
    Davis, Barry R.
    Piller, Linda B.
    Whelton, Paul K.
    Wright, Jackson T., Jr.
    Barzilay, Joshua I.
    Brown, Clinton D.
    Colon, Pedro J., Sr.
    Fine, Lawrence J.
    Grimm, Richard H., Jr.
    Gupta, Alok K.
    Baimbridge, Charles
    Haywood, L. Julian
    Henriquez, Mario A.
    Ilamaythi, Ekambaram
    Oparil, Suzanne
    Preston, Richard
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (06): : 989 - 1002
  • [37] Cardiovascular outcomes in hypertensives with coronary artery disease randomized to amlodipine versus lisinopril in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Leenen, F
    Nwachuku, C
    Cushman, W
    Black, H
    Simpson, L
    Davis, B
    JOURNAL OF HYPERTENSION, 2005, 23 : S21 - S22
  • [38] Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Piller, Linda B.
    Baraniuk, Sarah
    Simpson, Lara M.
    Cushman, William C.
    Massie, Barry M.
    Einhorn, Paula T.
    Oparil, Suzanne
    Ford, Charles E.
    Graumlich, James F.
    Dart, Richard A.
    Parish, David C.
    Retta, Tamrat M.
    Cuyjet, Aloysius B.
    Jafri, Syed Z.
    Furberg, Curt D.
    Saklayen, Mohammad G.
    Thadani, Udho
    Probstfield, Jeffrey L.
    Davis, Barry R.
    CIRCULATION, 2011, 124 (17) : 1811 - U88
  • [39] The anti hypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT) trial: Focus on the diabetic patient
    不详
    CURRENT HYPERTENSION REPORTS, 2004, 6 (03) : 212 - 214
  • [40] Response to letter regarding article, "Role of diuretics in the prevention of heart failure: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)"
    Davis, Barry R.
    Piller, Linda B.
    Dunn, Kay
    CIRCULATION, 2007, 115 (02) : E19 - E19
12345